XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) (UNAUDITED) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 50,252 $ 14,388,890 $ (150,000) $ (1,053,077) $ 13,236,065
Beginning balance, shares at Dec. 31, 2020 50,251,607        
Stock issued upon vesting of restricted stock $ 467 (467)
Stock issued upon vesting of restricted stock, shares 466,689        
Exercise of stock options $ 32 110,434 110,466
Exercise of stock options, shares 32,586        
Stock-based compensation 636,214 636,214
Net loss (1,623,527) (1,623,527)
Ending balance, value at Mar. 31, 2021 $ 50,751 15,135,071 (150,000) (2,676,604) 12,359,218
Ending balance, shares at Mar. 31, 2021 50,750,882        
Stock issued upon vesting of restricted stock $ 390 (390)
Stock issued upon vesting of restricted stock, shares 390,000        
Exercise of stock options $ 2 9,673 9,675
Exercise of stock options, shares 2,500        
Stock-based compensation 540,921 540,921
Net loss (931,967) (931,967)
Ending balance, value at Jun. 30, 2021 $ 51,143 15,685,275 (150,000) (3,608,571) 11,977,847
Ending balance, shares at Jun. 30, 2021 51,143,382        
Stock issued upon vesting of restricted stock $ 463 (463)
Stock issued upon vesting of restricted stock, shares 463,000        
Exercise of stock options $ 30 71,970 72,000
Exercise of stock options, shares 30,000        
Stock-based compensation 603,591 603,591
Net loss (271,006) (271,006)
Ending balance, value at Sep. 30, 2021 $ 51,636 16,360,373 (150,000) (3,879,577) 12,382,432
Ending balance, shares at Sep. 30, 2021 51,636,382        
Beginning balance, value at Dec. 31, 2021 $ 52,095 16,860,119 (150,000) (3,774,411) 12,987,803
Beginning balance, shares at Dec. 31, 2021 52,095,382        
Stock issued upon vesting of restricted stock $ 123 (123)
Stock issued upon vesting of restricted stock, shares 123,000        
Stock-based compensation 569,502 569,502
Net loss (309,395) (309,395)
Ending balance, value at Mar. 31, 2022 $ 52,218 17,429,498 (150,000) (4,083,806) 13,247,910
Ending balance, shares at Mar. 31, 2022 52,218,382        
Stock issued upon vesting of restricted stock $ 105 (105)
Stock issued upon vesting of restricted stock, shares 105,000        
Stock-based compensation 488,287 488,287
Net loss (228,034) (228,034)
Ending balance, value at Jun. 30, 2022 $ 52,323 17,917,680 (150,000) (4,311,840) 13,508,163
Ending balance, shares at Jun. 30, 2022 52,323,382        
Stock issued upon vesting of restricted stock $ 138 (138)
Stock issued upon vesting of restricted stock, shares 138,000        
Stock-based compensation 566,205 566,205
Net loss 852,109 852,109
Ending balance, value at Sep. 30, 2022 $ 52,461 $ 18,483,747 $ (150,000) $ (3,459,731) $ 14,926,477
Ending balance, shares at Sep. 30, 2022 52,461,382